19 /100
LOW RISK
Score updated May 29, 2026

TRDA — Entrada Therapeutics, Inc. Dilution Risk Tracker

Track TRDA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TRDA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for TRDA.
🔔 Track TRDA — Get forecast alerts →

💹 Market Data

Market Cap$264.76M
Shares Outstanding38.82M
Float19.47M
Cash$254.86M
Debt$49.75M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 14.4% shares (2025Q4 vs prior)
112 institutional holders · 24.76M shares
#1 BAKER BROS. ADVISORS LP 5.07M shares
#2 5AM Venture Management, LLC 4.06M shares
#3 BlackRock, Inc. 2.15M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest998.4K
Days to Cover5.5
% of Float5.1%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2021
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track TRDA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TRDA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for TRDA
📊 TRDA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 TRDA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.